ArticleEye (London, England)2026
Complications after radiotherapy in patients with Graves' orbitopathy: A nationwide cohort study.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Orbital Radiotherapy for Thyroid-Associated Orbitopathy in the Era of Targeted Biologics: Reposition, Not Replace.Medicina (Kaunas, Lithuania) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo analyse the incidence of complications following radiotherapy (RT) in patients with Graves' orbitopathy (GO), particularly focusing on the incidence of radiation retinopathy and associated risk factors.
methodsData on diagnosed GO patients who received RT between 2008 and 2018 were obtained from the National Health Insurance Service database. The diagnosis of GO and the administration of RT were assessed utilising the International Classification of Diseases codes. The incidence of RT-related complications was analysed. Logistic regression was used to identify risk factors for radiation retinopathy.
resultsAmong the 1108 patients who received RT for GO between 2008 and 2018, 67 patients (6.0%) were newly diagnosed with cataracts, and 42 patients (3.8%) underwent surgery. Ocular surface disease, dry eye syndrome, eyelid inflammation, and head and neck cancer occurred in 14 patients (1.3%), 37 patients (3.3%), 8 patients (0.7%), and 2 patients (0.2%), respectively, and no cases of leukaemia or lymphoma were observed. Radiation retinopathy developed in 63 patients (5.7%). In comparison to those without radiation retinopathy, patients with radiation retinopathy had a short interval from GO diagnosis to RT (odds ratio (OR) = 0.95, 95% CI = 0.92-0.98, p = 0.003) and high fasting blood sugar levels (OR = 1.01, 95% CI = 1.00-1.03, p = 0.014).
conclusionsIn patients with GO, cataract, radiation retinopathy, dry eye syndrome, ocular surface disease, and head and neck cancers are potential complications of orbital RT. Risk factor identification and long-term monitoring are crucial for minimising treatment-related complications and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.